{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:26:01Z","timestamp":1780392361615,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41409-021-01429-0","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T10:03:49Z","timestamp":1629194629000},"page":"2904-2910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma"],"prefix":"10.1038","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0366-3673","authenticated-orcid":false,"given":"Miquel","family":"Granell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Sen\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-5920","authenticated-orcid":false,"given":"Anna","family":"Barata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Teresa","family":"Cibeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Gironella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"L\u00f3pez-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1281-1495","authenticated-orcid":false,"given":"Cristina","family":"Motll\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Garcia-Gui\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Ben-Azaiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e8nia","family":"Abella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Ma","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-4042","authenticated-orcid":false,"given":"Rodrigo","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7966-0356","authenticated-orcid":false,"given":"Jorge","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4930-9255","authenticated-orcid":false,"given":"Carlos Fern\u00e1ndez","family":"de Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-2221","authenticated-orcid":false,"given":"Albert","family":"Oriol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2534-9239","authenticated-orcid":false,"given":"Laura","family":"Rosi\u00f1ol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Group for the Study of Myeloma and Amyloidosis of Catalonia (GEMMAC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"1429_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2354.2007.00729.x","volume":"16","author":"F Kennedy","year":"2007","unstructured":"Kennedy F, Haslam C, Munir F, Pryce J. Returning to work following cancer: a qualitative exploratory study into the experience of returning to work following cancer. Eur J Cancer Care. 2007;16:17\u201325.","journal-title":"Eur J Cancer Care"},{"key":"1429_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10926-015-9620-3","volume":"26","author":"HA D\u00e9siron","year":"2016","unstructured":"D\u00e9siron HA, Crutzen R, Godderis L, Van Hoof E, de Rijk A. Bridging health care and the workplace: formulation of a return-to-work intervention for breast cancer patients using an intervention mapping approach. J Occup Rehabil. 2016;26:350\u201365.","journal-title":"J Occup Rehabil"},{"key":"1429_CR3","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1093\/jnci\/djy172","volume":"110","author":"CJ Bradley","year":"2018","unstructured":"Bradley CJ, Brown KL, Haan M, Glasgow RE, Newman LS, Rabin B, et al. Cancer survivorship and employment: intersection of oral agents, changing workforce dynamics, and employers\u2019 perspectives. J Natl Cancer Inst. 2018;110:1292\u201399.","journal-title":"J Natl Cancer Inst"},{"key":"1429_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11764-020-00862-2","volume":"14","author":"AG de Boer","year":"2020","unstructured":"de Boer AG, Torp S, Popa A, Horsboel T, Zadnik V, Rottenberg Y, et al. Long-term work retention after treatment for cancer: a systematic review and meta-analysis. J Cancer Surviv. 2020;14:135\u201350.","journal-title":"J Cancer Surviv"},{"key":"1429_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/jama.2009.187","volume":"301","author":"AG de Boer","year":"2009","unstructured":"de Boer AG, Taskila T, Ojaj\u00e4rvi A, van Dijk FJ, Verbeek JH. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301:753\u201362.","journal-title":"JAMA"},{"key":"1429_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/pon.1843","volume":"20","author":"T Taskila","year":"2011","unstructured":"Taskila T, de Boer AG, van Dijk FJ, Verbeek JH. Fatigue and its correlates in cancer patients who had returned to work-a cohort study. Psychooncology. 2011;20:1236\u201341.","journal-title":"Psychooncology"},{"key":"1429_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/jnci\/djy176","volume":"110","author":"RM Kline","year":"2018","unstructured":"Kline RM, Arora NK, Bradley CJ, Brauer ER, Graves DL, Lunsford NB, et al. Long-term survivorship care after cancer treatment\u2014summary of a 2017 National Cancer Policy Forum Workshop. J Natl Cancer Inst. 2018;110:1300\u201310.","journal-title":"J Natl Cancer Inst"},{"key":"1429_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/pon.3909","volume":"25","author":"L Sharp","year":"2016","unstructured":"Sharp L, O\u2019Leary E, Kinnear H, Gavin A, Drummond FJ. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study. Psychooncology. 2016;25:282\u201391.","journal-title":"Psychooncology"},{"key":"1429_CR9","unstructured":"National Cancer Institute. SEER cancer stat facts: myeloma. Bethesda, MD: National Cancer Institute. https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.htm. Accessed Dec 2020."},{"key":"1429_CR10","first-page":"40","volume":"20","author":"DD Alexander","year":"2012","unstructured":"Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, et al. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer. 2012;20:40\u201361.","journal-title":"Int J Cancer"},{"key":"1429_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"1429_CR12","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1182\/blood-2012-02-408922","volume":"120","author":"L Rosi\u00f1ol","year":"2012","unstructured":"Rosi\u00f1ol L, Oriol A, Teruel AI, Hern\u00e1ndez D, L\u00f3pez-Jim\u00e9nez J, de la Rubia J, et al. Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA\/GEM study. Blood. 2012;120:1589\u201396.","journal-title":"Blood"},{"key":"1429_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","volume":"376","author":"M Attal","year":"2017","unstructured":"Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M, et al. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma. N Engl J Med. 2017;376:1311\u201320.","journal-title":"N Engl J Med"},{"key":"1429_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/leu.2014.23","volume":"28","author":"S Kristinsson","year":"2014","unstructured":"Kristinsson S, Anderson W, Landgren O. Improved long-term survival in multiple myeloma up to the age of 80 years. Leukemia. 2014;28:1346\u20138.","journal-title":"Leukemia"},{"key":"1429_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3324\/haematol.2017.178103","volume":"103","author":"CH Blimark","year":"2018","unstructured":"Blimark CH, Turesson I, Genell A, Ahlbert L, Bj\u00f6rkstrand, Carlson K, et al. Outcome and survival of myeloma patients diagnosed 2008\u201315. Real-world data on 4904 patients from the Swedish Myeloma Registry. Haematologica. 2018;103:506\u201313.","journal-title":"Haematologica"},{"key":"1429_CR16","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/bjh.16674","volume":"191","author":"\u00d8O Langseth","year":"2020","unstructured":"Langseth \u00d8O, Myklebust T\u00c5, Johannesen TB, Hjertner \u00d8, Waage A. Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982\u20132017. Br J Haematol. 2020;191:418\u201325.","journal-title":"Br J Haematol"},{"key":"1429_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/bloodadvances.2016002493","volume":"1","author":"LJ Costa","year":"2017","unstructured":"Costa LJ, Brill IK, Omel J, Godby K, Kumar SK, Brown EE. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States. Blood Adv. 2017;1:282\u20137.","journal-title":"Blood Adv"},{"key":"1429_CR18","unstructured":"Cancer Research UK. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/myeloma. Accessed Dec 2020."},{"key":"1429_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-018-0065-8","volume":"8","author":"P Ravi","year":"2018","unstructured":"Ravi P, Kumar SK, Cerhan JR, Maurer MJ, Dingli D, Ansell SM, et al. Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies. Blood Cancer J. 2018;8:26.","journal-title":"Blood Cancer J"},{"key":"1429_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s11764-013-0300-z","volume":"7","author":"TA Horsboel","year":"2013","unstructured":"Horsboel TA, Nielsen CV, Nielsen B, Jensen C, Andersen NT, de Thurah A. Type of hematological malignancy is crucial for the return-to-work prognosis: a register-based cohort study. J Cancer Surviv. 2013;7:614\u201323.","journal-title":"J Cancer Surviv"},{"key":"1429_CR21","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1001\/jama.291.19.2335","volume":"291","author":"KL Syrjala","year":"2004","unstructured":"Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers MED, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004;291:2335\u201343.","journal-title":"JAMA"},{"key":"1429_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11764-009-0105-2","volume":"4","author":"AC Kirchhoff","year":"2010","unstructured":"Kirchhoff AC, Leisenring W, Syrjala KL. Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv. 2010;4:33\u201344.","journal-title":"J Cancer Surviv"},{"key":"1429_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/annonc\/mdf031","volume":"13","author":"M Hensel","year":"2002","unstructured":"Hensel M, Egerer G, Schneeweiss A, Goldschmidt H, Ho AD. Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Ann Oncol. 2002;13:209\u201317.","journal-title":"Ann Oncol"},{"key":"1429_CR24","first-page":"249","volume":"12","author":"U Gruber","year":"2003","unstructured":"Gruber U, Fegg M, Buchmann M, Kolb HJ, Hiddemann W. The longterm psychosocial effects of haematopoetic stem cell transplantation. Eur J Cancer Care. 2003;12:249\u201356.","journal-title":"Eur J Cancer Care"},{"key":"1429_CR25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/bmt.2008.253","volume":"42","author":"S Bieri","year":"2008","unstructured":"Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B, et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2008;42:819\u201327.","journal-title":"Bone Marrow Transplant"},{"key":"1429_CR26","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/bmt.2017.115","volume":"52","author":"A Tichelli","year":"2017","unstructured":"Tichelli A, Gerull S, Holbro A, Buser A, Nair G, Medinger M, et al. Inability to work and need for a disability pension among long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017;52:1436\u201342.","journal-title":"Bone Marrow Transplant"},{"key":"1429_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/CLEP.S134603","volume":"9","author":"B Arboe","year":"2017","unstructured":"Arboe B, Olsen MH, Goerloev JS, Duun-Henriksen AK, Johansen C, Dalton SO, et al. Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation. Clin Epidemiol. 2017;9:321\u20139.","journal-title":"Clin Epidemiol"},{"key":"1429_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3109\/0284186X.2015.1125015","volume":"55","author":"CE Kiserud","year":"2016","unstructured":"Kiserud CE, Fagerli UM, Smeland KB, Fluge O, Bersvendsen H, Kvaloy S, et al. Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncol. 2016;55:547\u201353.","journal-title":"Acta Oncol"},{"key":"1429_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/ejh.13298","volume":"103","author":"G Jackson","year":"2019","unstructured":"Jackson G, Galinsky J, Alderson DEC, D\u2019Souza VK, Buchanan V, Dhanasiri S, et al. Productivity losses in patients with newly diagnosed multiple myeloma following stem cell transplantation and the impact of maintenance therapy. Eur J Haematol. 2019;103:393\u2013401.","journal-title":"Eur J Haematol"},{"key":"1429_CR30","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/cncr.28607","volume":"120","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Hawley ST, Abrahamse P, Li Y, Janz NK, Griggs JJ, et al. Impact of adjuvant chemotherapy on long-term employment of survivors of early-stage breast cancer. Cancer. 2014;120:1854\u201362.","journal-title":"Cancer"},{"key":"1429_CR31","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.2011.38.5401","volume":"31","author":"P Marino","year":"2013","unstructured":"Marino P, Teyssier LS, Malavolti L, Le Corroller-Soriano AG. Sex differences in the return-to-work process of cancer survivors 2 years after diagnosis: results from a large French population-based sample. J Clin Oncol. 2013;31:1277\u201384.","journal-title":"J Clin Oncol"},{"key":"1429_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.leukres.2017.05.019","volume":"59","author":"C Hulin","year":"2017","unstructured":"Hulin C, Hansen T, Heron L, Pughe R, Streetly M, Plate A, et al. Living with the burden of relapse in multiple myeloma from the patient and physician perspective. Leuk Res. 2017;59:75\u201384.","journal-title":"Leuk Res"},{"key":"1429_CR33","doi-asserted-by":"publisher","first-page":"8305","DOI":"10.1200\/JCO.2005.09.500","volume":"23","author":"M Drolet","year":"2005","unstructured":"Drolet M, Maunsell E, Brisson J, Brisson C, M\u00e2sse B, Desch\u00eanes L. Not working 3 years after breast cancer: predictors in a population-based study. J Clin Oncol. 2005;23:8305\u201312.","journal-title":"J Clin Oncol"},{"key":"1429_CR34","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1002\/cncr.31735","volume":"124","author":"LCG Landeiro","year":"2018","unstructured":"Landeiro LCG, Gagliato DM, F\u00eade AB, Fraile NM, Lopez RM, da Fonseca LG, et al. Return to work after breast cancer diagnosis: an observational prospective study in Brazil. Cancer. 2018;124:4700\u201310.","journal-title":"Cancer"},{"key":"1429_CR35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/archotol.132.1.32","volume":"132","author":"JG Vartanian","year":"2006","unstructured":"Vartanian JG, Carvalho AL, Toyota J, Kowalski IS, Kowalski LP. Socioeconomic effects of and risk factors for disability in long-term survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:32\u20135.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1429_CR36","unstructured":"https:\/\/www.ine.es\/jaxiT3\/Datos.htm. Accessed Apr 2021."}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01429-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01429-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01429-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T17:03:11Z","timestamp":1638378191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01429-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01429-0","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}